Alaunos Therapeutics | ZIOP - Операционные расходы





Операционные расходы Изменить Дата
Alaunos Therapeutics USD 1.01M 175K 2026-03
Amgen USD 4.78B 1.12B 2026-03
AstraZeneca USD 8.18B 4.35B 2026-03
Baxter International USD 6.04B 2.85B 2026-03
Biogen USD 1.96B 69.6M 2026-03
Bioline Rx USD 3.48M 99K 2026-03
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Celltrion KRW 140.68B 584.31B 2025-12
Corcept Therapeutics USD 214.5M 16.87M 2026-03
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Curis USD 9.02M 23.01M 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 47M 22.83M 2026-03
Divis Laboratories Ltd INR 20.17B 1.85B 2026-03
Gilead Sciences USD 23.52B 18.55B 2026-03
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
Incyte USD 5.62B 4.5B 2026-03
Intrexon USD 61.56M 26.1M 2024-06
Ionis Pharmaceuticals USD 364M 54M 2026-03
J&J USD 17.44B 1.53B 2026-03
Kangmei Pharma CNY 1.09B 304.02M 2026-03
Karyopharm Therapeutics USD 51.92M 9.9M 2025-12
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Merck USD 18.17B 8.01B 2026-03
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Novartis USD 9.29B 507M 2026-03
Organigram Holdings CAD 69.59M 14.08M 2026-03
Ovoca Bio EUR 1.16M 4.48M 2025-06
Pfizer USD 90.1B 77.19B 2026-03
Pharma Mar EUR 42.28M 4.59M 2026-03
PTC Therapeutics USD 226.66M 19.64M 2026-03
Qiagen NV USD 418.54M 23.25M 2025-12
Regeneron Pharmaceuticals USD 31.42B 28.44B 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sartorius EUR 738.4M 22.4M 2026-03
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
TG Therapeutics USD 170.12M 28.04M 2026-03
Tilray USD 237.52M 17.34M 2025-09
Verastem USD 59.01M 21.98M 2025-12
Zealand Pharma A/S 775.97M 265.08M 2025-12
Zz Pientze Pharmaceu CNY 1.88B 326.34M 2026-03